Kiniksa Pharmaceuticals International Insider Sold Shares Worth $8,937,067, According to a Recent SEC Filing

10:16 AM EST, 11/04/2026 (MT Newswires) -- John F. Paolini, Chief Medical Officer, on October 30, 2026, sold 96,000 shares in Kiniksa Pharmaceuticals International (KNSA) for $8,937,067. Following the Form 4 filing with the SEC, Paolini has control over a total of 69,922 Class A ordinary shares of the company, with 69,922 shares held directly. Sales were effected pursuant to a Rule 10b5-1 plan executed on July 29. SEC Filing: https://www.sec.gov/Archives/edgar/data/1730430/000174153326000012/xslF345X05/form4-11032026_111150.xml Price: 93.39, Change: +0.10, Percent Change: +0.11